Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Editor, Pharma Insights
{A1EF0A44-49EE-467F-964C-F748991F5552}
+15 year(s) experience
Scrip
By Sten Stovall 01 Nov 2019
Ruud Dobber oversees AstraZeneca’s biopharmaceuticals division, which generates some 40% of group total revenues. He tells Scrip to “Watch this space.”
Scrip
By Sten Stovall 23 Oct 2019
VC Firm Sofinnova’s Chair Papiernik Speaks After New Fund Launch The chairman of Sofinnova Partners told Scrip his newly launched biotech start-up fund aims to profit from Europe’s top science, relatively realistic asset prices, and geopolitical position between the US and China.
Scrip
By Sten Stovall 13 Jun 2019
Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.
Scrip
By Sten Stovall 22 Aug 2018
The managing director for Sanofi in the UK says clinical trials there will become less likely in future if access to innovative drugs doesn't improve, causing comparative standards of care to deteriorate.
Scrip
By Sten Stovall 17 Aug 2018
Flush with IPO funding, AI-focused healthcare technology group Sensyne Health will now ready additional products and find three more NHS trust partnerships. CEO Lord Drayson spoke to Scrip.
Topic Research Business strategies
Scrip
By Sten Stovall 12 Dec 2017
Successfully piecing together the agreed life sciences sector deal calls for the UK to embrace high-risk innovation.
Topic Brexit
Scrip
By Sten Stovall 05 Sep 2017
Vasant Narasimhan, who is replacing Joseph Jimenez as Novartis' CEO next year, is an advocate of automation and artificial intelligence in future drug discovery.
Topic Business strategies
Scrip
By Sten Stovall 01 Sep 2017
Ireland-based Jazz Pharma is extending its shift away from specialty pharma with an option-based deal with ImmunoGen involving three antibody-drug conjugate programs.
Topic Business strategies
Scrip
By Sten Stovall 23 Aug 2017
UK-based Destiny Pharma hopes its planned IPO will attract investor demand.
Topic Clinical trials
Scrip
By Sten Stovall 18 Jul 2017
Datamonitor Healthcare's latest sector analysis indicates that the pharma industry's 10 biggest companies.
Scrip
By Sten Stovall 26 Jun 2017
Flemming Ornskov says FDA approval of long-lasting ADHD therapy Mydayis.
Scrip
By Sten Stovall 19 Jun 2017
Roche CEO Severin Schwan says analysts at ASCO missed a key APHINITY message on Herceptin follow-on Perjeta.
Topic Research
Pink Sheet
By Sten Stovall 05 Apr 2017
Biogen's chief medical officer says iPhone technology should in future be used for early warning diagnosis of Alzheimer's Disease.
Topic Alzheimers
Pink Sheet
By Sten Stovall 15 Mar 2017
Discussion with regulators on conditional regulatory pathways will now begin after strong and durable immune responses against the Zaire Ebola virus were reported in a UK-based Phase I trial in healthy volunteers usingthefiloviruses vaccine Ad26.ZEBOV developed by Bavarian Nordic AS and licensed by Johnson & Johnson'sJanssen Pharmaceutical Cos.
Scrip
04 Dec 2019
Scrip
02 Dec 2019
Scrip
28 Nov 2019
Scrip
27 Nov 2019
Scrip
27 Nov 2019
Scrip
25 Nov 2019
Scrip
19 Nov 2019
Scrip
18 Nov 2019
Scrip
13 Nov 2019
Scrip
11 Nov 2019
Scrip
06 Nov 2019
Scrip
04 Nov 2019
Scrip
30 Oct 2019
Scrip
28 Oct 2019
Scrip
24 Oct 2019
Tweets from Sten